Empress Therapeutics Appoints Dawn Thompson, Ph.D., Senior Vice President, Head of Platform Development

Aug 16, 2023•almost 2 years ago

Position

Head Of Platform Development

Company

Empress Therapeutics

Dawn Thompson

CambridgeBiotechnology

Description

Empress Therapeutics, a company accelerating small molecule drug generation through novel insights linking genes to chemistry, today announced that Dawn Thompson, Ph.D., has been appointed Senior Vice President, Head of Platform Development. With more than 20 years of experience leading cross-functional teams and building technology platforms at early-stage companies, Dr. Thompson will focus at Empress on platform innovation, adding new workflows and advanced genomics capabilities as well as efficiency and scale to all existing functions.

Company Information

Company

Empress Therapeutics

Location

Cambridge, Maryland, United States

About

Founded by Flagship Pioneering in 2020, Empress Therapeutics generates good medicines, fast, by starting with chemistry inside the human body. The Empress Chemilogics(TM) platform uses novel insights that connect the lines of code in DNA with drug-like chemistry made in the human body to create first- or best-in-class oral medicines for a broad range of diseases quickly, predictably, and cost-effectively.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Virginia hidden

Dawn hidden

hidden